ABSTRACT
Background Disability in Parkinson’s disease (PD) is measured by standardised scales including the MDS-UPDRS, which are subject to high inter and intra-rater variability and fail to capture subtle motor impairment. The BRadykinesia Akinesia INcoordination (BRAIN) test is a previously validated keyboard tapping test, evaluating proximal upper-limb motor impairment. Here, a new Distal Bradykinesia Tapping (DBT) test was developed to assess distal upper-limb function. Kinetic parameters of the test include kinesia score (KS20, key taps over 20 seconds), akinesia time (AT20, mean dwell-time on each key) and incoordination score (IS20, variance of travelling time between key taps).
Objective To develop and validate a new keyboard-tapping test to assess distal motor function in PD patients.
Methods The DBT test was validated in 45 PD patients and 24 controls, alongside the BRAIN test. Test scores were compared between groups and correlated with MDS-UPDRS-III scores. 10 additional PD patients were recruited to assess the DBT test in monitoring motor fluctuations.
Results All three parameters discriminated between patients and controls, with KS20 performing best, yielding 75% sensitivity for 85% specificity; area under the receiver operating characteristic curve (AUC) = 0.87. Combination of both the DBT and BRAIN tests improved discrimination (AUC=0.91). KS20 and AT20 correlated with MDS-UPDRS-III (Pearson’s r=-0.49, p<0.001 and r=0.54, p<0.001, respectively). The DBT test detected subtle changes in motor fluctuation states, which were not reflected clearly by MDS-UPDRS-III sub-scores.
Conclusion The DBT test is a user-friendly method of assessing distal motor dysfunction in PD, possibly permitting longitudinal monitoring of PD motor complications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr. Noyce is funded by the Barts Charity. Dr. Noyce reports additional grants from Parkinson's UK, Virginia Kieley benefaction, grants and non-financial support from GE Healthcare, and personal fees from Profile, Roche, Biogen, Bial and Britannia, outside the submitted work. Dr. Simonet is funded by Fundacion Alfonso Martin Escudero, Spain. No other disclosures were reported.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The authors confirm that all participants gave verbal and written consent for this work. Ethics approval was granted by the Queen Square Research Ethics Committee (09/H0716/48).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding agencies: There was no specific funding awarded for this study.
Financial Disclosures: Dr. Noyce is funded by the Barts Charity. Dr. Noyce reports additional grants from Parkinson’s UK, Virginia Kieley benefaction, grants and non-financial support from GE Healthcare, and personal fees from Profile, Roche, Biogen, Bial and Britannia, outside the submitted work. Dr. Simonet is funded by Fundación Alfonso Martín Escudero, Spain. No other disclosures were reported.
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.